Skip to Main Content

Paper Details

Fluvoxamine vs Placebo and Time to Recovery in Outpatients With Mild to Moderate COVID-19-Reply.
JAMA
1
2023
COVID-19, Fluvoxamine
Antiviral Agents, COVID-19, COVID-19 Drug Treatment, Double-Blind Method, Fluvoxamine, Humans, Recovery of Function, Time Factors
Author NameAffiliation
Matthew W McCarthy
Christopher J LindsellVanderbilt University Medical Center
Christopher J LindsellDuke University School of Medicine
Susanna NaggieDuke Clinical Research Institute
  • 1 - 4

Datasets

Release 1.2